Conyers provided Cayman legal advice for Proteologix, Inc. (“Proteologix”) in connection with the acquisition of Proteologix by Johnson & Johnson (NYSE: JNJ), for US$850 million in cash with potential for an additional milestone payment.

Proteologix is a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases.

Partner Richard Hall of Conyers’ Hong Kong office advised on the matter, working alongside Godwin Procter LLP.

Stay current with our latest legal insights and subscribe today